Ramon Lopez1, Mark O Farber, Vincent Wong, Steven E Lacey. 1. Indiana University, Fairbanks School of Public Health, Department of Environmental Health Science (Drs Lopez, Lacey); Indiana University Health, Pulmonology-Critical Care (Dr Farber); and Indiana University, Krannert Institute of Cardiology, Department of Medicine, Indianapolis (Dr Wong).
Abstract
OBJECTIVE: We conducted an exposure chamber study in humans using a simulated clinical procedure lasing porcine tissue to demonstrate evidence of effects of exposure to laser-generated particulate matter (LGPM). METHODS: We measured pre- and post-exposure changes in exhaled nitric oxide (eNO), spirometry, heart rate variability (HRV), and blood markers of inflammation in five volunteers. RESULTS: Change in pre- and post-exposure measurements of eNO and spirometry was unremarkable. Neutrophil and lymphocyte counts increased and fibrinogen levels decreased in four of the five subjects. Measures of HRV showed decreases in the standard deviation of normal between beat intervals and sequential 5-minute intervals. CONCLUSION: These data represent the first evidence of human physiologic response to LGPM exposure. Further exploration of coagulation effects and HRV is warranted.
OBJECTIVE: We conducted an exposure chamber study in humans using a simulated clinical procedure lasing porcine tissue to demonstrate evidence of effects of exposure to laser-generated particulate matter (LGPM). METHODS: We measured pre- and post-exposure changes in exhaled nitric oxide (eNO), spirometry, heart rate variability (HRV), and blood markers of inflammation in five volunteers. RESULTS: Change in pre- and post-exposure measurements of eNO and spirometry was unremarkable. Neutrophil and lymphocyte counts increased and fibrinogen levels decreased in four of the five subjects. Measures of HRV showed decreases in the standard deviation of normal between beat intervals and sequential 5-minute intervals. CONCLUSION: These data represent the first evidence of human physiologic response to LGPM exposure. Further exploration of coagulation effects and HRV is warranted.
Authors: D R Gold; A Litonjua; J Schwartz; E Lovett; A Larson; B Nearing; G Allen; M Verrier; R Cherry; R Verrier Journal: Circulation Date: 2000-03-21 Impact factor: 29.690
Authors: P A Steerenberg; J B Snelder; P H Fischer; J G Vos; H van Loveren; J G van Amsterdam Journal: Eur Respir J Date: 1999-02 Impact factor: 16.671
Authors: S Salvi; A Blomberg; B Rudell; F Kelly; T Sandström; S T Holgate; A Frew Journal: Am J Respir Crit Care Med Date: 1999-03 Impact factor: 21.405
Authors: Scott W Burchiel; Fredine T Lauer; Debra MacKenzie; Shea McClain; Philip J Kuehl; Jacob D McDonald; Kevin S Harrod Journal: Inhal Toxicol Date: 2016 Impact factor: 2.724
Authors: Ronald Sroka; Philip Janda; Tina Killian; Francis Vaz; Christian S Betz; Andreas Leunig Journal: Lasers Surg Med Date: 2007-04 Impact factor: 4.025